Company
Every investor coverage indicates participated in a round Wellington UniVentures raised.
Companies Wellington UniVentures acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Wellington UniVentures. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Brandon Capital's site announces it led $14m for Amaroq Therapeutics, an Otago spinout developing RNA-based cancer treatments — the firm's first deal as a government-backed incubator. The piece also recalls Kea Therapeutics' shutdown.
Brandon Capital led a NZ$14 million investment in Amaroq Therapeutics, a University of Otago spinout developing RNA cancer therapies, with three co-investors and a Callaghan Innovation repayable grant supporting the deal.
New Zealand timber construction startup X-Frame completed a first capital raise of $485,000, supported by Adelaide incubator Innovyz and Green Industries South Australia, with funds earmarked for product and platform development.